住院患者中的抗胆固醇负担:关于埃塞俄比亚流行率,决定因素和对死亡率的影响的横截面研究
Eyob Alemayehu Gebreyohannes1,2,3, Wagaye Atalay Taye4, Biniam Siyum Shibe4
1Quality Use of Medicines and Pharmacy Research Centre, UniSA Clinical and Health Sciences, University of South Australia, City East Campus, Frome Road, Adelaide, SA 5000, Australia.
超过一半的成年住院患者有抗胆固醇负担 (ACB). 高ACB与更长的住院时间和心理健康障碍有关,但与年轻人群的住院死亡率无关.
科学领域:
- 老年学是指老年学的学科.
- 临床药房 临床药房
- 公共卫生 公共卫生
背景情况:
- 抗胆固醇负担 (ACB) 与不良健康结果有关,包括住院治疗和认知障碍.
- 对ACB的研究往往低于低收入和中等收入环境以及年轻成人人口.
研究的目的:
- 确定成人住院患者中ACB的患病率和危险因素.
- 评估ACB对冈达尔大学综合专门医院 (UOGCSH) 住院死亡率的影响.
主要方法:
- 在UOGCSH对420名成年住院患者进行了横截面研究.
- 数据通过问卷和医疗图表收集;使用连续抽样.
- 统计分析包括描述性统计,千二测试和Cox比例危险回归.
主要成果:
- 58.3%的患者接触过抗胆固醇药物;11.2%的患者有高ACB (≥3).
- 高ACB与每名患者服用更多药物,住院时间更长,精神/行为障碍相关.
- 在ACB和住院死亡率之间没有发现显著的关联.
结论:
- 在这种成年住院患者群体中,抗胆固醇药物的使用率很高.
- 更高的抗胆固醇负担与住院时间的增加有关,即使在年轻人中也是如此.
- 抗胆固醇负担在本研究队列中没有显著影响住院死亡率.
更多相关视频
03:25Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
Published on: December 27, 2024
04:53Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
Published on: October 18, 2024
相关概念视频
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Cholinergic Antagonists: Pharmacokinetics
Cholinergic Antagonists: Pharmacological Actions
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Direct-Acting Cholinergic Agonists: Pharmacokinetics
